| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | BHC Bausch Health Companies Inc. | Papa Joseph C | Chairman &CEO | Buy | 30,000 | $23.67 | $710,100.00 | +4.4% | |
| Feb 28, 2019 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 27,725 | $58.83 | $1,630,931.30 | -0.6% | |
| Feb 28, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 520,688 | $0.05 | $25,108.72 | -0.2% | |
| Feb 27, 2019 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | Sr VP, Chief Financial Officer | Sell | 20,000 | $41.53 | $830,650.00 | -29.5% | |
| Feb 27, 2019 | TXMD Therapeuticsmd, Inc. | Musing Jules A. | Director | Sell | 17,400 | $5.80 | $100,920.00 | -77.7% | |
| Feb 27, 2019 | LNTH Lantheus Holdings, Inc. | Orlandi Cesare | Chief Medical Officer | Sell | 3,111 | $23.10 | $71,870.32 | -3.6% | |
| Feb 27, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | See Remarks | Sell | 2,360 | $23.17 | $54,681.20 | -1.4% | |
| Feb 26, 2019 | ANIK Anika Therapeutics, Inc. | Land Raymond J | Director | Sell | 4,000 | $33.06 | $132,240.00 | -21.1% | |
| Feb 25, 2019 | TLRY Tilray Brands, Inc. | Castaneda Mark | CFO, Secretary, Treasurer | Sell | 40,000 | $78.09 | $3,123,452.07 | -53.6% | |
| Feb 25, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 9,456 | $24.06 | $227,518.92 | -1.5% | |
| Feb 22, 2019 | AMRN Amarin Corp Plc\uk | Peterson Kristine | Director | Sell | 163,500 | $20.02 | $3,274,038.45 | -100% | |
| Feb 22, 2019 | AMRN Amarin Corp Plc\uk | Van Heek G Jan | Director | Sell | 203,382 | $20.02 | $4,071,422.91 | -93.5% | |
| Feb 22, 2019 | AMRN Amarin Corp Plc\uk | Kalb Michael Wayne | SVP And CFO | Sell | 50,000 | $18.97 | $948,500.00 | -70.9% | |
| Feb 22, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 195,000 | $124.19 | $24,217,635.00 | -0.2% | |
| Feb 22, 2019 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Sell | 180,625 | $19.90 | $3,594,437.50 | -68.1% | |
| Feb 22, 2019 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 95,953 | $80.01 | $7,677,541.11 | -6.5% | |
| Feb 21, 2019 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 1,644 | $14.31 | $23,525.77 | -0.1% | |
| Feb 21, 2019 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | Chief Financial Officer | Sell | 5,677 | $14.31 | $81,238.33 | -0.4% | |
| Feb 21, 2019 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Commercial Officer | Sell | 4,841 | $14.31 | $69,275.12 | -0.9% | |
| Feb 21, 2019 | IRWD Ironwood Pharmaceuticals Inc | Gilbert Halley E | Chief Legal Officer | Sell | 10,242 | $14.31 | $146,563.87 | -0.6% | |
| Feb 20, 2019 | YCBD Cbdmd, Inc. | Sumichrast Martin A.83 | Chairman Of The Board And CEO | Sell | 150,000 | $4.00 | $600,000.00 | -20.1% | |
| Feb 20, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 8,100 | $1.43 | $11,623.00 | - | |
| Feb 19, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $122.48 | $25,108,512.92 | - | |
| Feb 19, 2019 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 135,613 | $80.03 | $10,853,105.55 | -8.9% | |
| Feb 15, 2019 | LLY Eli Lilly & Co | Conterno Enrique A87 | SVP&Pres, Lillydiab &Lillyusa | Sell | 25,000 | $121.00 | $3,025,000.00 | -15.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.